Authorization Legislation Still On Congress Busy Agenda, Along With Risk Assessment, Appropriations
In Brief: Four To Share In $100,000 Hammer Prize; Oldham To Head New Genetic Engineering Firm In Texas
Seer Gets Concept Approve For Five More Years From Ad Hoc Committee Since Two PLs Are DCPC Board Members
ACS Probably Will Accept Hammer’s Offer On Matching Funds For Survey
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Cancer patients with Medicare Advantage have access to fewer providers than Medicare patients, cross-sectional study finds
- A new diagnostic lens—and a lasting scientific legacy
- A chronotherapy study in Nature Medicine showed dramatic results. Then it was retracted.
The phase III trial claimed a staggering boost to OS and PFS when immunochemotherapy was given before 3 p.m. - OMB’s plan to increase political control of science faces stiff opposition on Capitol Hill
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives









